Comparison of Pulse Oximetry (SpO2) With Different Oximeters and Arterial Saturation (SaO2): Oxygap2 Study
Launched by LAVAL UNIVERSITY · Oct 25, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The Oxygap2 Study is a clinical trial that is looking at how well different types of oximeters measure oxygen levels in patients who are in the Intensive Care Unit (ICU) and receiving oxygen therapy. Oximeters are devices that help monitor how much oxygen is in the blood. The study aims to compare the readings from various oximeters—such as those made by General Electric, Medtronic, Masimo, and Nonin—with a more precise method called arterial gas measurement. This is important because having accurate readings can help doctors make better decisions about how to manage oxygen levels, ensuring patients receive the right amount of oxygen and avoid complications.
To participate in this study, you must be at least 18 years old and admitted to the ICU with an artery catheter already in place. Unfortunately, people with certain conditions, such as very low blood oxygen levels or specific infections, may not be eligible. If you join the study, you'll help researchers gather important information that could lead to improved recommendations for oxygen therapy in the future. This is a great opportunity to contribute to advancements in patient care while receiving close monitoring during your treatment.
Gender
ALL
Eligibility criteria
- • Adult population
- Inclusion Criteria:
- • ≥ 18 years old (adult population) -
- • Patients admitted to the Intensive Care Unit
- • Artery catheter already installed
- • Pediatric population
- • Below 18 years old
- • Patients admitted to the Intensive Care Unit
- • Artery catheter already installed
- Exclusion Criteria:
- • No or poor signal with the usual pulse oximeter/based on clinician judgment
- • High dose of vasopressors or inotropes (epinephrine or norepinephrine ˃ 1mcg/kg/min), shock state (lactates above 3 mmoles/L)
- • Pigmented nails or nail polish
- • Methemoglobinemia history
- • Hemoglobin below 80 g/L
- • Patient in isolation (multi-resistant bacteria, C-Difficile, SARS-COV-2...)
- • Prone position, Extra Corporel Membrane Oxygenator
About Laval University
Laval University is a prestigious research institution located in Quebec, Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. The university actively engages in clinical trials aimed at exploring new therapeutic interventions and improving patient outcomes. With a strong emphasis on ethical standards and rigorous scientific methodologies, Laval University collaborates with multidisciplinary teams of researchers, healthcare professionals, and industry partners to conduct high-quality clinical research. Its state-of-the-art facilities and dedication to fostering a culture of inquiry position Laval University as a leader in clinical research, contributing significantly to the understanding and treatment of diverse medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Quebec, , Canada
Montréal, Quebec, Canada
Montréal, Quebec, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported